Urinary Catheters Market worth $2.6 billion by 2025 - Exclusive Report by MarketsandMarkets™11/30/2021 According to the new market research report "Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) & Region - Global Forecast To 2025", published by MarketsandMarkets™, the global Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period.
Browse in-depth TOC on "Urinary Catheters Market" 125 – Tables 35 – Figures 165 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market. In 2019, the indwelling catheters segment accounted for the largest share of the urinary catheters market Based on products, the global market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market. The coated catheter segment is expected to grow at the highest CAGR during the forecast period By catheter type, the global market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction. North America was the largest regional market for urinary catheters market in 2019 The market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019. The large share of North America in this market can be attributed to the favorable reimbursement scenario and the rising volume of surgeries in the region. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The high growth in this market can be attributed to the growing healthcare spending in emerging Asian countries, rising prevalence of urinary incontinence, and the large target patient population in the region. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132934629 The global urinary catheters market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US). Other players include Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India). Browse Related Reports: Urology Devices Market by Product ((Endoscopes, Robotic, Lasers & Lithotripsy, Dialysis, Urodynamic Systems), (Guidewires, Catheters, Biopsy Devices)), Disease (Kidney Disease, Urologic Cancer, Pelvic Organ Prolapse), End User - Global Forecast to 2026 https://www.marketsandmarkets.com/Market-Reports/urology-devices-market-173062212.html Catheters Market by Type (Cardiovascular (IVUS Catheter, Guiding Catheter, Balloon Catheter), Urology catheter (Dialysis, Foley, Intermittent Catheter), Intravenous Catheter (Central Venous Catheter)), & End User (Hospital) - Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/catheters-market-6247803.html
0 Comments
According to the new market research report "Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, Nanofiltration), Material (PES, PVDF, PTFE), Application (Final Product (Sterile Filtration), Raw Material, Cell Separation, Water) - Global Forecast to 2025", published by MarketsandMarkets™, the global Pharmaceutical Membrane Filtration Market is expected to grow from USD 5.8 billion in 2020 to USD 10.2 billion by 2025, at a CAGR of 12.0% from 2020 to 2025.
Browse in-depth TOC on "Pharmaceutical Membrane Filtration Market" 326 – Tables 36 – Figures 248 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031 The major factors driving the growth of this market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market. Filters segment accounted for the largest share of the pharmaceutical membrane filtration market, by product, in 2019 On the basis of product, the market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry. Final product processing segment accounted for the largest share of the pharmaceutical membrane filtration market, by application, in 2019 On the basis of application, the market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the market in 2019. The increasing production of generics, rapid growth in the biopharmaceutical industry, and the increasing adoption of membrane filters in protein purification, sterile filtration, and viral clearance processes are the major factors driving the growth of this application segment. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031 In 2019, North America was the largest regional market for pharmaceutical membrane filtration The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest market for pharmaceutical membrane filtration, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US. The major companies operating in the pharmaceutical membrane filtration market include Merck (Germany), Danaher (US) and Sartorius Stedim Biotech (France). Browse Related Reports: Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF), Ceramic), Technique (Microfiltration, Ultrafiltration), Application (Harvest & Clarification, Concentration, Diafiltration), End Users (Pharma, Biotech, CRO, CMO) - Global Forecast to 2026https://www.marketsandmarkets.com/Market-Reports/hollow-fiber-filtration-market-267011039.html Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-filtration-market-209343847.html According to a new market research report " Medical Image Analysis Software Market by Type (Standalone), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Dental, Oncology, Nephrology), End User (Hospital, Diagnostic Centre, Research) - Global Forecasts to 2022", published by MarketsandMarkets™, the market is expected to reach USD 3.88 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 8.2% during the forecast period.
Browse in-depth TOC on " Medical Image Analysis Software Market " 303 – Tables 43 – Figures 313 – Pages Download PDF Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=846 The growth of the market is attributed to technological advancements in medical imaging systems & analysis software, growing public- and private-sector investments in the medical imaging market, increasing use of imaging equipment due to rising prevalence of chronic diseases, fusion of imaging technologies, and growing applications of computer-aided diagnosis. Growing need for automated image analysis tools, rising adoption of cloud-based imaging solutions, and untapped emerging markets are expected to offer significant growth opportunities for manufacturers in the coming years. Integrated software to dominate the market in 2017 Based on type, the Medical Image Analysis Software Market is segmented into integrated and standalone software. In 2017, the integrated software segment is expected to account for the largest share of the Medical Image Analysis Software Market. The compatibility of the software with the equipment is examined by the manufacturer beforehand and easy handling and fast processing are additional factors that contribute to the adoption of integrated image analysis software. However, the standalone software segment is expected to grow at the highest CAGR during the forecast period. Standalone software offers high flexibility and easy-to-use tools to inspect, evaluate, and process imaging data. These advantages are driving its growth in the market. On the basis of end user, hospitals are projected to grow at the highest CAGR By end user, the Medical Image Analysis Software Market is segmented into hospitals, diagnostic centers, and research centers. Hospitals are expected to register the highest CAGR during the forecast period. The greater use of medical imaging software in hospitals & the higher installed base of diagnostic imaging systems (as compared to diagnostic and research centers) and high patient inflow (as compared to diagnostic centers) are expected to boost the demand for medical image analysis software in this segment. North America to dominate the market followed by Europe In 2017, North America is expected to account for the largest share of the market. The high growth of the North American market is attributed to the factors such as the growing geriatric population, high incidence/prevalence of various diseases, the large number of imaging centers in this region, ongoing research, fast adoption of technologically advanced imaging systems, and increasing awareness about the benefits of early disease diagnosis. In 2017, Europe is expected to hold the second largest share of this market. Talk To Our Research Analysts: -http://www.marketsandmarkets.com/speaktoanalyst.asp?id=846 Factors such as rising incidence of chronic diseases and injuries, increasing demand for non-radiation diagnostic solutions, technological advancements and new product launches, large number of ongoing research activities, and increasing government and public-private investments are expected to fuel the market growth in this region. The Medical Image Analysis Software Market is highly competitive with the presence of several small and big players. Some of the players in the Medical Image Analysis Software Market include AGFA Healthcare (Belgium), AQUILAB (France), Carestream Health, Inc. (US), Esaote S.p.A (Italy), GE Healthcare (US), Image Analysis (UK), INFINITT Healthcare Co, Ltd. (South Korea), Merge Healthcare, Inc. (US), MIM Software Inc. (US), Mirada Medical Limited (UK), Philips Healthcare (Netherlands), ScienceSoft USA Corporation (US), Siemens Healthineers (Germany), Toshiba Medical Systems Corporation (Japan), and Xinapse Systems Ltd (UK). According to the new market research report "High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025", published by MarketsandMarkets™, the global High-Throughput Screening Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3 billion in 2020, at a CAGR of 11.5% during the forecast period.
Browse in-depth TOC on "High-Throughput Screening (HTS) Market" 432 – Tables 40 – Figures 319 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950 The HTS Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the market. The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019. On the basis type of product & service, the HTS Market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening (HTS) market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research. The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019. Based on application, the HTS Market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure. Request Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950 The Asia Pacific region is the fastest-growing region of the high-throughput screening market in 2019. In 2019, Asia Pacific region accounted for the fastest-growing region of the HTS Market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the market in this region. Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg). Browse Related Reports: Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html Cell Analysis Market Worth $22.7 Billion by 2024 - Exclusive Market Report by MarketsandMarkets™11/25/2021 According to the new market research report "Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024", published by MarketsandMarkets™, the Cell Analysis Market is expected to reach USD 22.7 billion by 2024 from USD 16.0 billion in 2019, at a CAGR of 7.2%. from 2019 to 2024
Browse and in-depth TOC on "Cell Analysis Market" 209 - Tables 36 - Figures 230 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 The Increasing government funding for cell-based research and the rising incidence of chronic and infectious diseases are the major factors driving the growth of this market. In 2018, the flow cytometry products segment accounted for the largest share of the cell analysis market Based on product, the Cell Analysis Market is broadly categorized into microscopes, flow cytometry products, spectrophotometers, qPCR products, cell counters, cell microarrays, high-content screening (HCS) systems, and other products. The flow cytometry products segment accounted for the largest market share in 2018. The large share of this segment is primarily attributed to technological advancements, the increasing adoption of flow cytometry techniques in research and academia, growing public-private initiatives in the field of immunology and immuno-oncology research, and the rising incidence and prevalence of chronic diseases. The pharmaceutical & biotechnology companies and CROs segment to grow at the highest CAGR during the forecast period Based on end user, the Cell Analysis Market is segmented into hospitals & diagnostic laboratories, research institutes, pharmaceutical & biotechnology companies and CROs, cell culture collection repositories, and other end users. The pharmaceutical & biotechnology companies and CROs segment is expected to register the highest CAGR during the forecast period. These facilities use cell analysis instruments and consumables during various stages of drug discovery, drug research and development, pharmacokinetics, toxicology, and clinical studies. Growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R&D expenditure, and commercial expansion of various pharmaceutical companies are driving the growth of this end-user segment. Get 10% Customization Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=157543946 North America was the largest regional market for cell analysis in 2018 By region, the Cell Analysis Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the presence of a favorable business environment, growing government support through funds and grants, growing number of research activities, rising number of drug discovery initiatives by pharmaceutical & biotechnology companies in the US, and the strong presence of key players in this region are driving the growth of the Cell Analysis Market in North America. The prominent players operating in the Cell Analysis Market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), GE Healthcare (US), Agilent Technologies, Inc. (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), Promega Corporation (US), Tecan Group (Switzerland), Miltenyi Biotec (Germany), Carl Zeiss (Germany), Bio-Rad Laboratories Inc (US), and Sysmex Corporation (Japan). According to the new market research report "Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Home Care, ACC, Emergency Medical Services) Covid-19 Impact - Global Forecast to 2025", published by MarketsandMarkets™, the market is driven by the outbreak of the covid-19 pandemic, high prevalence of respiratory diseases, rapid growth in the geriatric population, increasing number of preterm births, and the rising number of ICU beds. However, factors such as dearth of skilled medical workers, reimbursement concerns, complications associated with the use of ventilators, reluctance among physicians for the adoption of new technologies are expected to restrain the growth of this market to a certain extent during the forecast period.
Browse in-depth TOC on "Ventilator Market" 190 – Tables 57 – Figures 250 – Pages Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11018337 By mobility, the intensive care segment to witness the highest growth in the market Based on mobility, the market for ventilators is segmented into intensive care ventilators and portable/transportable ventilators. The intensive care ventilators segmented is estimated to be USD 5.5 billion in 2020. It is expected to grow at AGR of 535.4% from 2019 to 2020.The intensive care ventilators segment is projected to witness the highest growth in the market during the forecast period. Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators. The increasing ICU admission due to COVID-19 and readmissions in developed countries coupled with appropriate reimbursement is also responsible for the growth of the ICU ventilators segment. The ICU ventilators segment is further sub-segmented into high-end ICU ventilators, mid-end ICU ventilators, and basic ICU ventilators. On the basis of type, the adult/pediatric ventilators segment is expected to account for the largest share of the ventilators market in 2019 Based on type, the market for ventilators is segmented into adult/pediatric ventilators and neonatal/infant ventilators. The adult/pediatric ventilators segment accounted for the largest share of the market in 2019. The large share of this segment is largely driven by the large adult population suffering from COVID-19, chronic diseases such as COPD & asthma, the high prevalence of smoking, and the rising geriatric population. By interface, the invasive ventilation segment to witness the highest growth in the ventilators market Based on the interface, the market for ventilators is segmented into invasive ventilation and non-invasive ventilation segment. The invasive ventilation segment is projected to witness the highest growth in the intensive care ventilator market during the forecast period. Growth in the invasive ventilation market can be attributed to increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders. On the basis of mode, the combined-mode ventilation segment is expected to account for the largest share of the ventilator market in 2019 Based on the mode of ventilation, the market is segmented into volume-mode ventilation, pressure-mode ventilation, combined-mode ventilation, and other modes. The combined-mode ventilation segment accounted for the largest share of the market. The large share of the segment is attributed to its advantages over conventional pressure-mode ventilation and volume-mode ventilation. The ability of combined-mode ventilation to provide both modes of ventilation makes it a desirable product in the market. By end-user, the emergency medical services segment to witness the highest growth in the ventilators market On the basis of end-user, the ventilator market is segmented into hospitals and clinics, home care, ambulatory care center, and emergency medical services. The emergency medical services segment is projected to witness the highest growth in the market during the forecast period. Growth in this segment is attributed to the high incidence of trauma injuries, such as road accidents and falls, sports injuries, and criminal injuries. Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION:: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=11018337 North America to dominate the ventilator market during the forecast period North America is expected to account for the largest share of the market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising geriatric population, high prevalence of smoking, high prevalence of respiratory diseases, increasing COVID-19 patient volume, highly developed healthcare system, high healthcare expenditure, and major market players in the US. The prominent players in the intensive care ventilators market are Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US). Revenue Cycle Management Market worth $67.8 billion by 2026 - Exclusive Report by MarketsandMarkets™11/22/2021 According to the new market research report "Revenue Cycle Management/RCM Market by Product & Services (Eligibility Verification, Clinical Coding, CDI, Claims Processing, Denial Management, Outsourcing Services, Cloud), End User(Payers, Hospitals, Outpatient), Covid-19 Impact - Global Forecast to 2026", published by MarketsandMarkets™, the global RCM Market is projected to reach USD 67.8 billion by 2026 from USD 40.9 billion in 2021, at a CAGR of 10.6% during the forecast period.
Browse in-depth TOC on "Revenue Cycle Management Market" 242 – Tables 40 – Figures 286 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153900104 The growth of this market is majorly attributed to the need for increasing patient volumes, and the growing need to manage unstructured healthcare data. Also, growing regulatory requirements & government initiatives are expected to drive demand growth in the IoT medical devices market during the forecast period. By product & services, segment the outsourcing services segment is expected to grow at the highest growth rate during the forecast period Among the product & services, the outsourcing services segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the lack of IT infrastructure and the shortage of skilled HCIT personnel. By delivery mode, the on-premise segment is expected to account for the largest share of the revenue cycle management market The on-premise segment accounted for the largest share of the global RCM Market in 2020. The large share of this segment is attributed to the increasing demand for mobile support systems for better customer (patient) engagement platforms. By end user, the healthcare providers segment is expected to account for the largest share of the RCM Market Based on end user, the revenue cycle management market is segmented into healthcare providers and healthcare payers. Revenue cycle management solutions help healthcare providers automate the process from patient registration to billing and claims processing and provide better transparency that improves the overall financial health of the provider organization. This is a major factor driving the growth of this segment. Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=153900104 North America dominates the revenue cycle management market during the forecast period. North America accounted for the largest share of the RCM Market in 2020. The large share of this region can be attributed to factors such as stringent regulations, increasing volume of claims denials, the presence of a high number of private healthcare payers and well-established government payers, and a large number of healthcare IT companies are some of the factors driving the growth of the revenue cycle management market in this region. R1 RCM (US), Cerner Corporation (US), Optum (US) are the leading players in the market. Other players include McKesson Corporation (US), Change Healthcare (US), 3M (US), Experian plc (Ireland), Conifer Health Solutions (US), Allscripts Healthcare Solutions (US), GE Healthcare (US), Cognizant (US), athenahealth (US), SSI Group LLC (US), AdvantEdge Healthcare (US), and Huron Consulting Group (US) Browse Related Reports: Healthcare EDI Market by Component (Solution, Service), Delivery Mode (On-premise & Cloud, Mobile) Transaction Type (Claims Management, Payment Remittance, Payments, Healthcare Supply Chain), End-User - Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/healthcare-edi-market-130571438.html Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2024https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html According to the new market research report "Nucleic Acid Isolation and Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic) - Global Forecast to 2025", published by MarketsandMarkets™, the global Nucleic Acid Isolation and Purification Market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period.
Browse in-depth TOC on "Nucleic Acid Isolation and Purification Market" 116 – Tables 34 – Figures 191 – Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287 The growth of this market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. On the other hand, the high cost of automated instruments is expected to hinder the growth of the market. By product, the kits segment accounted for the largest market share in 2019. On the basis of product, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The kits segment accounted for the largest share of the global nucleic acid isolation and purification market in 2019. Growth in this market can be attributed to the low cost and easy usage of kits in applications such as gene sequencing, molecular diagnostics, and gene cloning. By application, the diagnostics segment accounted for the largest market share in 2019. On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. In 2019, the diagnostics segment accounted for the largest share of the global nucleic acid isolation and purification market; this segment is also expected to register the highest CAGR during the forecast period. The large share and high growth rate of this segment can be attributed to the growing awareness of genomic diagnostics among patients and the increasing efficiency of genomics sequencing in the diagnosis of diseases. By Type, the plasmid DNA isolation and purification segment accounted for the largest market share in 2019. On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. In 2019, the plasmid DNA isolation segment accounted for the largest share of the market. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection. Get 10% Customization on this Research Report :- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=229978287 North America dominates the nucleic acid isolation and purification market during the forecast period. In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe. The large share of this region can be attributed to factors such as significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region. However, the Asia Pacific region is expected to grow at the highest rate during the forecast period QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation and purification market. Other prominent players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany). Browse Related Reports: Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/isothermal-nucleic-acid-amplification-technologies-inaat-market-839.html Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html Label-free Detection Market worth $626 million by 2025 - Exclusive Report by MarketsandMarkets™11/18/2021 According to the new market research report "Label-free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chip), Software), Technology (Surface Plasmon Resonance), Application (Binding Kinetics), End User (Pharmaceutical & Biotechnology Companies) & region - Global Forecast to 2025", published by MarketsandMarkets™, the global Label-Free Detection Market size is estimated to be USD 431 million in 2020 and projected to reach USD 626 million by 2025, at a CAGR of 7.7%.
Browse in-depth TOC on "Label-free Detection Market" 187 – Tables 29 – Figures 193 – Pages Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32435593 The Growth in this market is largely driven by the introduction of technologically advanced products, a growing number of drug discovery programs through academic-industrial partnerships, and the high sensitivity of label-free technologies. The instruments segment accounted for the largest share of the product & service segment in the label-free detection market in 2019. On the basis of product & service, the market is broadly segmented into instruments, consumables and software & services. The consumables segment is further segmented into biosensor chips, microplates and reagents & kits. In 2019, instruments accounted for the largest share of the label-free detection products market owing to the various technological advancements in label-free detection systems. The surface plasmon resonance segment accounted for the largest share of the technology segment in the market in 2019. On the basis of technology, the market is categorized into five technology segments—surface plasmon resonance, bio-layer interferometry, differential scanning calorimetry, isothermal titration calorimetry, and other label-free detection technologies. The surface plasmon resonance segment accounted for the largest share in 2019, due to the high sensitivity of this technology and its wide usage in determining specificity, affinity, and kinetic parameters during the binding of macromolecules. The Asia Pacific region is the fastest growing region of the label-free detection market in 2019. In 2019, Asia Pacific region accounted for the fastest growing region of the market. It is also estimated to grow at the highest CAGR in the market during the forecast period, this is mainly due to the rising awareness, increasing government support and funding, and growth in life science research. Get 10% Customization on this Research Report:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593 Some of the leading players in the label-free detection market include Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer Inc. (US), AMETEK, Inc. (US), HORIBA Ltd. (Japan), Spectris (UK), METTLER TOLEDO (US), Corning Incorporated (US), and Agilent Technologies, Inc. (US) Browse Related Reports: Cell Analysis Market by Product [Microscope, Spectrophotometers, Flow cytometry (Software, Accessories)], Process (Cell Viability, Cell Proliferation, Signal Transduction), End User (Pharma, Research, Biotechnology Companies) - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html High-Throughput Screening (HTS) Market by Product (Instruments, Software, Service), Technology (Cell-Based Assays, Label-Free), Application (Drug Discovery, Biochemical Screening, Research), End User (Pharma & Biotech, CROs)- Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html According to the new market research report "Healthcare Interoperability Solutions Market by Type (EHR Interoperability, Health Information Exchange, Enterprise), Interoperability Levels (Foundational, Structural, Semantics), End User and Region - Global Forecast to 2024", published by MarketsandMarkets™, the Healthcare Interoperability Solutions Market is expected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%.
Browse in-depth TOC on "Healthcare Interoperability Solutions Market" 100 – Tables 28 – Figures 174 – Pages Download PDF Brochure :- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847 The major factors driving the growth of this market include the growing need to curb increasing healthcare costs and a growing focus on patient-centric care delivery. Moreover, government initiatives for enhancing patient care & safety and government funding for healthcare interoperability are also boosting market growth. By type, the services segment is expected to account for the largest share of the Healthcare Interoperability Solutions Market Based on type, the Healthcare Interoperability Solutions Market is segmented into software and services. The services segment is estimated to account for the largest market share in 2019. The large share of this segment can be attributed to the shifting era towards cloud computing and reduced operational costs for better and faster performance of business processes and applications. This segment includes integration and application management services, support & maintenance services, implementation services, and training and education services. By software type, the HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period Based on software type, the Healthcare Interoperability Solutions Market is segmented into EHR interoperability solutions, lab system interoperability solutions, imaging system interoperability solutions, HIE interoperability solutions, enterprise interoperability solutions, and other interoperability solutions. The HIE interoperability solutions segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the need for greater access to patient health information and the growing adoption of healthcare IT solutions to enhance patient satisfaction and improve quality care. North America to dominate the Healthcare Interoperability Solutions Market during the forecast period North America is expected to account for the largest share of the Healthcare Interoperability Solutions Market in 2019, followed by Europe. The dominance of the North American region can be attributed to the rising demand for quality healthcare delivery, a need to curb increasing healthcare expenditure, and the implementation of favorable initiatives & regulations to improve the overall efficiency of healthcare organizations in the region. Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=17705847 The prominent players in the Healthcare Interoperability Solutions Market are Cerner Corporation (US), Infor, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), iNTERFACEWARE (Canada), Quality Systems, Inc. (US), OSP Labs (US), Epic Systems Corporation (US), ViSolve, Inc. (US), and Jitterbit (US). |
AuthorWe are providing and consulting the healthcare Industry Research Report. Archives
March 2022
Categories |